home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Radiation Toxicity — Considerations for Implementing Radiation Dose Limits in Radiopharmaceutical Trials

 
  October 25, 2022  
     
 
Xtalks, online
2022 -11-16


As the radiopharmaceutical research and development landscape continues to advance, so do the complexities and challenges associated with clinical trials. Conducting radiopharmaceutical trials presents a unique set of obstacles, such as the challenge of capturing unique radiation induced toxicities in the context of enrolled patients’ overall radiation exposure. This requires an understanding of enrolled patients’ cumulative radiation exposure from previous radiation treatments and current studies. For clinical radiopharmaceutical studies, the broader team must understand the background of radiation dosimetry, radiation toxicity, normal organ dose constraints and how to capture these metrics within clinical trial data management.
 
In this webinar, Medpace medical, operational, regulatory and core lab experts will explore considerations for radiation toxicity and analyze previous radiopharmaceutical case studies and draw on their 30+ years of integrated, global experience to examine strategies to successfully operationalize complex radiopharmaceutical trials and increase the probability of clinical and regulatory success.
 
Register for this webinar to learn how sponsors in the pharma and biotech industry can overcome challenges associated with complex radiopharmaceutical trials through medical, regulatory and operational considerations, including engaging an experienced and full-service clinical research partner with cross-functional expertise.
 
Click here to learn more about Medpace’s radiation therapy solutions.
 
 
Organized by: Xtalks
Invited Speakers: Jess Guarnaschelli, MD, Senior Medical Director, Medical Department, Medpace Stephanie Millin, PhD, Clinical Trial Manager, Medpace Deborah Hirscher, MBA, MS, RN, ARNP, FNP, Senior Director, Clinical Trial Management, Medpace James Thomas, BSc (Hons), MA, Senior Director, Regulatory Submissions, Medpace Daphnée Villoing, PhD, Dosimetry Specialist and Senior Project Manager, Medpace Core Labs
 
Deadline for Abstracts: 2022 -11-16
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.